Dinko Rekić

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 7

Top Topics

Heart Rate Variability

Top Venues

Pharmacology research & perspectives

Clinical pharmacokinetics

CPT: pharmacometrics & systems pharmacology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Joanna Parkinson, Jesper Sundell, Dinko Rekić, Karin Nelander, Hans Ericsson, Ahmad Ebrahimi, Corina Dota, Mikael Sunnåker
The myeloperoxidase inhibitor mitiperstat (AZD4831) does not prolong the QT interval at expected therapeutic doses. Pharmacology research & perspectives 12 (2) (2024)
Jane Knöchel, Catarina Nilsson, Björn Carlsson, Linda Wernevik, Alexis Hofherr, Peter Gennemark, Rasmus Jansson-Löfmark, Rikard Isaksson, Tina Rydén-Bergsten, Bengt Hamrén, Dinko Rekić
A case-study of model-informed drug development of a novel PCSK9 anti sense oligonucleotide. Part 1: First time in man to phase II. CPT: pharmacometrics & systems pharmacology (2022)
Dinko Rekić, Ivan Azarov, Jane Knöchel, Victor Sokolov, Catarina Nilsson, Linda Wernevik, David Han, Tina Rydén-Bergsten, Ahmad Ebrahimi, Corina Dota, Björn Carlsson
AZD8233 antisense oligonucleotide targeting PCSK9 does not prolong QT interval. British journal of clinical pharmacology 88 (11) (2022)
Yasunori Aoki, Claudia S Cabrera, Mario Ouwens, Krister Bamberg, Jenny Nyström, Itamar Raz, Benjamin M Scirica, Bengt Hamrén, Peter J Greasley, Dinko Rekić
Bilirubin levels and kidney function decline: An analysis of clinical trial and real world data. PloS one 17 (6) (2022)
Dinko Rekić, Virginie Kerbusch-Herben, Mats Någård, James Chou, Jiayin Huang, Charles Bradley, Magnus Åstrand, Stacey Tannenbaum, Bengt Hamrén
Pharmacokinetics of Roxadustat: A Population Analysis of 2855 Dialysis- and Non-Dialysis-Dependent Patients with Chronic Kidney Disease. Clinical pharmacokinetics 60 (6) (2021)
Dinko Rekić, Susanne Johansson, Jacob Leander
Higher Febuxostat Exposure Observed in Asian Compared with Caucasian Subjects Independent of Bodyweight. Clinical pharmacokinetics 60 (3) (2020)